Test ID HTLVL Human T-Cell Lymphotropic Virus Types I and II (HTLV-I/-II) Antibody Confirmation, Serum
Useful For
Confirmatory detection of human T-cell lymphotropic virus types I and II (HTLV-I and HTLV-II)-specific IgG antibodies in human serum specimens that are consistently reactive by initial screening tests
Differentiating between HTLV-I- and HTLV-II-specific IgG antibodies
Method Name
Line Immunoassay (LIA)
Reporting Name
HTLV-I/-II Ab Confirmation, SSpecimen Type
Serum SSTOrdering Guidance
This confirmatory assay should be ordered only on serum specimens that are consistently reactive by an antihuman T-cell lymphotropic virus 1 and 2 (anti-HTLV-I/-II) screening immunoassay. For an evaluation that includes screening and confirmation, order HTLVI / Human T-Cell Lymphotropic Virus Types I and II Antibody Screen with Confirmation, Serum.
For testing spinal fluid specimens, order HTLLC / Human T-Cell Lymphotropic Virus Types 1 and 2 (HTLV-1/-2) Antibody Confirmation, Spinal Fluid.
Necessary Information
Date of collection is required.
Specimen Required
Collection Container/Tube: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Centrifuge blood collection tube per collection tube manufacturer's instructions (eg, centrifuge and aliquot within 2 hours of collection for BD Vacutainer tubes).
2. Aliquot serum into plastic vial.
Specimen Minimum Volume
0.2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum SST | Frozen (preferred) | ||
Refrigerated | 7 days |
Reference Values
Negative
Day(s) Performed
Tuesday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86689
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
HTLVL | HTLV-I/-II Ab Confirmation, S | 55162-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
83277 | HTLV-I/-II Ab Confirmation, S | 22362-8 |
23898 | HTLV-I/-II Bands | 61112-9 |
23899 | HTLV-I/-II Discrimination | 77744-1 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
2 to 15 daysNY State Approved
YesForms
If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.